C25 (Rubraca 250 mg)
Generic Name: rucaparib
Pill with imprint C25 is White, Four-sided and has been identified as Rubraca 250 mg. It is supplied by Clovis Oncology, Inc..
Rubraca is used in the treatment of ovarian cancer and belongs to the drug class PARP inhibitors. Rubraca 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C25
Rubraca
- Generic Name:
- rucaparib
- Imprint:
- C25
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- PARP inhibitors
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Clovis Oncology, Inc.
- Manufacturer:
- Clovis Oncology, Inc.
- National Drug Code (NDC):
- 69660-0202
More about Rubraca (rucaparib)
- Rubraca Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews
- Drug class: PARP inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
